Agreement with Thermo Fisher Scientific Inc. $40 million.
Latest 100 — Business partnerships
New York City time, the previously-announced separation (the Separation ) of Mobility Global Inc. ( Mobility Global ) from S P Global Inc.
New York City time, the previously-announced separation (the Separation ) of Mobility Global Inc. ( Mobility Global ) from S P Global Inc.
Entered into License Agreement with TAP, Inc.
Supplement to Supply and Distribution Agreement As previously disclosed in its Current Report on Form 8-K filed on February 2, 2026, on February 1, 2026, iPower Inc, a Nevada corporation ( iPower or the Company ), entered into a supply and distribution agreement (the SDA ) with its formerly-wholly owned subsidiary, Global Product Marketing, Inc., a Nevada corporation ( GPM ), and its 100% stockholder, ETTS AI Investment LLC, a Nevada limited liability company ( ETTS AI ). On June 30, 2026, the C
Entered into Amended and Restated Agreements and Plans of Merger.
Entered into Agreement and Plan of Merger with Patrick, inc.
On June 30, 2026 , Non-Invasive Monitoring Systems, Inc. (the Amendment ) to (i) extend the Outside Termination Date (as defined in the Agreement and Plan of Merger and Reorganization) dated March 6, 2026 (the Agreement )), (ii) provide for certain resale registration rights for a holder of a convertible note and (iii) revise certain of the closing conditions set forth in Sections 5.1 and 5.3 of the Agreement.
Entered into Agreement and Plan of Merger with Rocket Lab Corp.
✦Iridium Communications agreed to merge with Rocket Lab in an all-stock transaction, combining satellite communications with launch services capabilities and creating an integrated space infrastructure provider.
Entered into Agreement and Plan of Merger with Iridium Communications Inc.
✦Rocket Lab (RKLB) agreed to merge with Iridium Communications (IRDM), combining the satellite communications companies and creating a larger competitor in the space technology sector.
Entered into Trademark License Agreement with Honeywell, inc.
✦Honeywell Aerospace Inc. established a Trademark License Agreement with parent company Honeywell International, allowing the aerospace division to utilize Honeywell's brand assets for its operations and products.
Entered into Agreement and Plan of Merger with Parent, inc.
Entered into Agreement and Plan of Merger with PubCo. $50 million.
Entered into Agreement and Plan of Merger with Berry Aviation, Inc. $105 million.
Entered into Agreement and Plan of Merger.
Entered into Agreement and Plan of Merger.
Entered into Agreement and Plan of Merger with Black Pearl Equities II, LLC.
✦Selectis Health (GBCS) agreed to merge with Black Pearl Equities II, LLC, potentially resulting in a change of control that investors should monitor for deal terms and timing details.
Entered into Securities Purchase Agreement with Mackay Precious Metals Inc.
Entered into Agreement and Plan of Merger.
Entered into Agreement and Plan of Merger with Parent, inc.
✦Arcosa (ACA) entered into a merger agreement with Parent Inc., potentially signaling a significant corporate restructuring that could affect shareholder value and ownership structure.
Entered into Agreement and Plan of Merger with Chicago Atlantic Real Estate Finance, Inc.
Entered into Agreement and Plan of Merger with Chicago Atlantic BDC, Inc.
Entered into Agreement and Plan of Merger. $60.0 billion.
✦SpaceX has agreed to a $60 billion merger, significantly reshaping the aerospace and defense sector and potentially affecting valuations of competing space exploration companies.
Entered into Agreement and Plan of Merger with ANV Group Holdings Ltd.
Entered into Merger Agreement.
Entered into Collaboration Agreement with South Palm Cardiovascular Associates, LLC.
Entered into Agreement and Plan of Merger.
✦Fox Corporation agreed to acquire Roku in an all-stock deal, combining Fox's media distribution with Roku's streaming platform to strengthen competitive positioning against Netflix and Amazon.
Entered into Intellectual Property License Agreement.
Entered into Equity Distribution Agreement with Maxim Group LLC.
Immediately following the First Merger, Azora merged with and into Second Merger Sub, pursuant to which Second Merger Sub was the surviving entity and a wholly owned subsidiary of the Company (together with the First Merger, the Merger ). The Merger is intended to qualify as a tax-free reorganization for U.S.
Entered into Supply Agreement with Jiun Jiang Enterprise Co.
Entered into Agreement and Plan of Merger. $532,426,000 million.
Entered into Contribution Agreement with Eagle Road Oil, LLC.
Entered into Name and Likeness License Agreement.
(the Company or Lisata ) and Kuva Labs Inc., a Delaware corporation ( Parent ), together with Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ( Purchaser ), entered into an amendment and waiver (the Amendment ) to the previously announced Agreement and Plan of Merger, dated as of March 6, 2026, by and among Parent, Purchaser and the Company (as it may be amended from time to time, the Merger Agreement ). The Amendment also extended the Outside Date (as defi
Agreement with Cycurion Merger Sub, LLC.
On June 4, 2026, the Parties entered into the Second Amendment (the Amendment ) to the Merger Agreement, pursuant to which the definition of Fully Diluted Company Shares was revised to include the aggregate number of Open World ordinary shares issuable in connection with any existing agreement to issue Equity Interests (as such term is defined in the Merger Agreement) of Open World. The foregoing description of the Amendment does not purport to be complete and subject to, and is qualified in its
Agreement with DC Kati Venture LLC. $3.5 million.
Entered into Agreement and Plan of Merger and Reorganization with Treeline Biosciences, Inc. $2.5 billion.
Entered into Equity Distribution Agreement with Goldman Sachs Co.
Entered into Amended and Restated Exclusive License Agreement with MIRALOGX LLC.
Fourth Amendment to the License Agreement On June 2, 2026, Mineralys Therapeutics, Inc. Under the Amendment, the license granted by Tanabe to the Company related to lorundrostat was amended and restated to grant to the Company an exclusive, worldwide, royalty-free, sublicensable, perpetual and irrevocable license to the licensed intellectual property, and the Company will no longer have any diligence obligations to Tanabe with respect to the ongoing development or commercialization of lorundrost
( BP United ), which amends that certain Intellectual Property License Agreement, dated as of May 12, 2026, between the Company and BP United (the IP Agreement ). The Original Agreement contemplated that the parties would enter into an Exclusive Supply Agreement (the Supply Agreement ) to facilitate the transactions contemplated by the Original Agreement.
Entered into Asset Purchase Agreement with Vaximm AG.
✦OSR Holdings acquired assets from Vaximm AG through an asset purchase agreement, potentially expanding its operational capabilities and product portfolio.
Entered into Purchase and Sale Agreement and Escrow Instructions with DC Kapalua 1 Property, LLC.
Entered into agreement and plan of merger with HC2 Broadcasting Holdings Inc. $75 million.
Entered into Separation and Distribution Agreement with FedEx Freight Holding Company, Inc.
Entered into Agreement and Plan of Merger with DigitalBridge Operating Company, LLC. $650 million.
Agreement with MIRALOGX LLC.
Collaboration Agreement and Supply Agreement with Niowave On May 25, 2026, Aptevo Research and Development LLC ( Aptevo Research ), a subsidiary of Aptevo Therapeutics Inc. ( Niowave ) entered into a collaboration agreement (the Collaboration Agreement ) to collaborate on the development of a potential human therapeutic product incorporating Aptevo s proprietary molecules (including APVO455) and Niowave s proprietary radioisotopes (including Actinium-225).
Entered into Agreement and Plan of Merger with Cycurion Merger Sub-Halo, Inc. $1.0 million.
Entered into Master Collaboration and License Agreement.
✦Aspira Women's Health secured a Master Collaboration and License Agreement, potentially expanding its product portfolio and revenue streams through partnerships or technology access.
Entered into Agreement and Plan of Merger with Neo North Star Resources, Inc.
Entered into Agreement and Plan of Merger.
✦Bayview Acquisition Corp (BAYA) has entered into a merger agreement, signaling a potential business combination that could create value through consolidation or strategic alignment for shareholders.
Agreement with Raymond James Associates, Inc. $2.0 billion.
✦Capital Southwest Corporation expanded its distribution capacity by establishing a $2.0 billion agreement with Raymond James Associates, significantly enhancing its ability to raise capital for investments.
Entered into Agreement and Plan of Merger. $360 million.
✦NextEra Energy agreed to acquire Duke Energy's commercial renewables business for $360 million, expanding its clean energy portfolio.
Entered into Agreement and Plan of Merger with MMS USA Holdings, Inc.
✦LiveRamp Holdings agreed to merge with MMS USA Holdings in an all-cash transaction, providing shareholders with liquidity and ending the company's independent public trading status.
Agreement with BioAtla, Inc. $4.5 million.
✦Context Therapeutics licensed technology to BioAtla for $4.5 million, providing CNTX with upfront cash while diversifying revenue streams through strategic partnerships.
Entered into Merger Agreement.
On May 11,2026 , the Company issued a press release, filed as Exhibit 99, concerning a strategic partnership, distribution, and revenue sharing agreement with Amarox for regulatory affairs, marketing and potential commercialization of Multikine (Leukocyte Interleukin, Injection) in the treatment of head and neck cancer in Saudi Arabia, with an optional extension for the Gulf Cooperation Council (GCC) countries including Bahrain, Kuwait, Oman, Qatar, and the United Arab Emirates.
Entered into Agreement and Plan of Merger with Garda Therapeutics, Inc.
✦Assertio Holdings agreed to merge with Garda Therapeutics, combining the two specialty pharmaceutical companies into a single entity to enhance market position and operational efficiency.
Entered into Agreement and Plan of Merger with RTB Digital, Inc.
Agreement with Rigel Pharmaceuticals, Inc. $40.0 million.
Entered into Asset Purchase Agreement with Bora Pharmaceuticals Co. $122.5 million.
✦MacroGenics acquired Bora Pharmaceuticals' assets for $122.5 million, potentially expanding its oncology pipeline and diversifying its therapeutic portfolio through this strategic purchase.
Entered into Equity Distribution Agreement with BTIG, LLC.
Entered into Agreement and Plan of Merger.
✦Cross Country Healthcare agreed to merge, creating potential shareholder value through a strategic combination that will be determined by the final transaction terms and regulatory approval.
Entered into agreement and plan of merger with Polar Merger Sub, LLC. $40 million.
✦Core Scientific agreed to be acquired by Polar Merger Sub in a transaction valued at $40 million, significantly diluting existing shareholders' equity value.
The Amended Equity Distribution Agreement allows for sales pursuant to the Amended Equity Distribution Agreement to continue under the Company s currently effective shelf registration statement. The offering is being made pursuant to the Company s effective shelf registration statement on Form N-2 (Registration No.
✦Oxford Square Capital Corp. renewed its equity distribution agreement, enabling continued at-the-market share sales under its existing shelf registration to raise capital efficiently without repeated SEC filings.
(the Company or Lisata ) and Kuva Labs Inc., a Delaware corporation ( Parent ), together with Kuva Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ( Purchaser ), entered into an amendment and waiver (the Amendment and Waiver ) to the previously announced Agreement and Plan of Merger, dated as of March 6, 2026, by and among Parent, Purchaser and the Company (the Merger Agreement ). Under the Amendment and Waiver, Parent has also agreed to pay certain expenses of
✦Lisata Therapeutics amended its merger agreement with Kuva Labs, with Kuva agreeing to cover additional company expenses, modifying terms of the previously announced acquisition deal.
Entered into Agreement and Plan of Merger with Global Net Lease, Inc.
✦Modiv Inc. agreed to merge with Global Net Lease, Inc., combining the two net lease REITs in a significant consolidation that will create a larger real estate investment entity.
Entered into Confidential Settlement and Mutual Release Agreement with Inscobee Inc.
✦Apimeds Pharmaceuticals (APUS) settled disputes with Inscobee Inc. under confidential terms, resolving mutual claims through a release agreement that eliminates legal liabilities for both parties.
Entered into Amended and Restated Agreement and Plan of Merger with Garda Therapeutics, Inc.
✦Assertio Holdings agreed to merge with Garda Therapeutics under an amended merger agreement, potentially consolidating the two pharmaceutical companies and reshaping Assertio's corporate structure.
Agreement with Sag. $60.0 million.
✦MacroGenics licensed technology to Sage Therapeutics for $60 million upfront, providing near-term revenue while validating its platform and potentially generating future royalties.
Entered into Agreement and Plan of Merger with BNCCORP, Inc. $130.7 million.
✦OppFi agreed to merge with BNCCORP in an all-stock deal valued at $130.7 million, expanding its financial services platform through banking capabilities and customer access.
Entered into Arrangement Agreement and Plan of Merger with Parent, inc. $60 million.
✦RE/MAX Holdings agreed to be acquired by Parent Inc. for $60 million, representing a significant transaction that will result in the company being taken private.
LLC ( Goldman Sachs ), JonesTrading Institutional Services LLC, J.P. Morgan Securities LLC, Keefe, Bruyette Woods, Inc., Morgan Stanley Co.
✦Dynex Capital engaged Goldman Sachs, Morgan Stanley, J.P. Morgan, and other major financial institutions as underwriters for a securities distribution, likely facilitating capital raising through a coordinated offering process.
Entered into Securities Purchase Agreement with Dawson James Securities, Inc. $12 million.
✦Auddia Inc. secured $12 million in financing through a Securities Purchase Agreement with Dawson James Securities, providing capital to support operations and strategic initiatives.
Agreement with Brookfield Oaktree Holdings Canada Inc.
✦Brookfield Oaktree Holdings established a distribution agreement with its Canadian subsidiary, potentially streamlining capital flows and operational efficiency between the U.S. and Canadian entities.
Entered into Agreement and Plan of Merger.
✦Peoples Bancorp Inc (PEBO) has agreed to merge with Fiserv subsidiary, creating a combined entity that will strengthen both companies' financial services capabilities and market position.
Entered into Agreement and Plan of Merger with WILL CO.
✦Electro-Sensors Inc (ELSE) agreed to merge with WILL CO, combining the two companies into a single entity and potentially creating synergies for shareholders.
Entered into Agreement and Plan of Merger.
✦Helix Energy Solutions agreed to merge with an unspecified entity; investors should await additional details on deal terms, valuation, and strategic rationale in forthcoming SEC filings.
Agreement with MeiraG. $105 million.
✦MeiraGTx entered a $105 million collaboration agreement, likely expanding its gene therapy pipeline and providing significant funding for development programs.
Entered into Shares Issuance Agreement with Broadcast Music, LLC.
✦LiveOne entered a shares issuance agreement with Broadcast Music, LLC, potentially diluting existing shareholders while expanding its music licensing capabilities and revenue opportunities.
Entered into Collaboration Agreement with Kare Rx Hub, LLC.
✦Wellgistics Health entered a collaboration agreement with Kare Rx Hub, LLC, potentially expanding its pharmaceutical distribution and healthcare services capabilities through strategic partnership.
Entered into Asset Purchase and Exclusive License Agreement with Celularity Inc.
✦NexGel acquired an exclusive license to commercialize Celularity's technology through an asset purchase agreement, potentially expanding its product portfolio and market reach.
Entered into Agreement and Plan of Merger with QXO, Inc.
✦TopBuild Corp. agreed to merge with QXO, Inc., combining the two companies and likely creating a larger building products and installation services competitor in the construction industry.
Entered into Agreement and Plan of Merger.
✦Sila Realty Trust (SILA) has entered into a merger agreement, though the filing doesn't disclose the acquirer or deal terms, leaving investors needing additional details to assess impact.
The Merger Agreement, the Form of Voting Agreement, and the Form of Registration Rights Agreement relating to the transactions contemplated by the Merger Agreement (the Transactions ) are included as Exhibits 2.1, 10.1 and 10.2 hereto, respectively, and are incorporated herein by reference. The material terms of the Merger Agreement, the Voting Agreement, and the Registration Rights Agreement were previously described in USAR s Current Report on Form 8-K filed on April 20, 2026, which descriptio
✦USA Rare Earth (USAR) has filed merger agreement documentation with voting and registration rights agreements, completing disclosure of previously announced transaction terms from April 2026.
Entered into Agreement and Plan of Merger with TopBuild Corp.
✦QXO agreed to merge with TopBuild Corp., creating a combined entity that will strengthen both companies' positions in the construction and building products sectors.
Entered into Mutual Collaboration Agreement with Foris DAX Markets, Inc.
✦High Roller Technologies (ROLR) entered into a mutual collaboration agreement with Foris DAX Markets, expanding its business partnerships and potentially opening new revenue opportunities through the combined expertise of both companies.
Entered into Collaboration Agreement with Kare Rx Hub, LLC.
✦Wellgistics Health (WGRX) has established a collaboration agreement with Kare Rx Hub, LLC, potentially expanding its pharmaceutical distribution and healthcare service capabilities through this partnership.
orld, Ltd., (incorporated herein by reference from Exhibit 2.2 to the Company s Registration Statement on Form S-4, filed on April 15, 2026). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
✦VRME announced a merger agreement, signaling potential significant operational changes and shareholder dilution or cash considerations that will reshape the company's business structure and investor value.
Agreement with Apple Inc.
✦Globalstar's merger with Apple could dramatically increase valuation and provide significant capital, but investors should monitor deal terms and regulatory approval risks.
Agreement with American Industrial Partners.
✦AVNS shareholders will likely face significant dilution or a below-market acquisition price, as private equity takeovers typically involve substantial management fees and leverage that prioritize buyer returns over public shareholders.
Agreement with ThirdEye Systems Ltd. $10.
✦AeroVironment (UAVS) and partner formed a joint venture with ThirdEye Systems for $10M, potentially expanding drone capabilities and creating new revenue streams that could accelerate growth in the commercial robotics market.
Agreement with Leggett Platt, Inc. $64.
✦SGI shareholders will receive $64 per share in cash from Leggett Platt, representing a definitive merger agreement that likely concludes the company's independent operations and provides certainty on exit valuation.
Entered into each of the Supplemental Indentures following receipt of the requisite con with Madison Parent Inc.
✦Comcast's supplemental indentures with Madison Parent suggest debt restructuring ahead of a potential merger, which could dilute existing shareholders or increase financial leverage.
r Common Stock), each right entitling the holder thereof to receive one-tenth (1/10) of a share of Acquirer Common Stock upon the consummation of an initial business combination; and (D) to provide that either the Company or the Acquiror has the right to terminate the Merger Agreement if either party has made a written request of the other party pursuant to the Merger Agreement and five Business Days have passed, and the requesting party has not received a response. The foregoing summary of the
✦FGMC announced a merger agreement with termination rights after five business days without response, meaning shareholders face execution risk and potential deal collapse if negotiations stall.
quirer Common Stock upon the consummation of an initial business combination; and (D) to provide that either the Company or the Acquiror has the right to terminate the Merger Agreement if either party has made a written request of the other party pursuant to the Merger Agreement and five Business Days have passed, and the requesting party has not received a response. The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendm
✦FGMC's merger agreement was amended to include termination rights if either party fails to respond within five business days, reducing deal certainty and increasing risk that the combination fails.
Entered into Equity Distribution Agreement with Maxim Group LLC. $3.0.
✦AIM can raise up to $3.0 million through Maxim Group LLC, providing capital flexibility without debt while diluting existing shareholders unless proceeds fund accretive growth.